Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1149 per EA under NDC 72888006660. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
30 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006660
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521On Market Since
3/16/2021
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.1910 (Nov 16, 2022) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.1250 |
| Average price | $0.1321 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1149 per EA (NDC 72888006660), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 28.6%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Jun 1, 2022, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.1910 (Nov 16, 2022), with a median of $0.1250 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 72888006660) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification